TEHRAN (ANA)- In a revealing preclinical study, the weight-loss drug tirzepatide—already known for fighting obesity and diabetes—unexpectedly slowed the growth of breast cancer tumors in obese mice.
TEHRAN (ANA)- Findings of a study challenge long-standing assumptions about therapy-related cancers and they also highlight how drug actions can substitute for genetic changes in tumor development.
TEHRAN (ANA)- Researchers have discovered that dormant breast cancer cells can be detected and wiped out with existing drugs, dramatically lowering the risk of relapse and the breakthrough brings new hope to survivors haunted by the fear of recurrence.
TEHRAN (ANA)- A powerful new pill has been shown to bring down stubbornly high blood pressure that resists standard treatments, according to results from a landmark global trial.
TEHRAN (ANA)- Iranian scientists at the Royan Research Institute’s Cord Blood Bank started treatment of patients with severe arthritis with umbilical cord stem cells, describing the initial results as highly successful.
TEHRAN (ANA)- For over 40 years, beta blockers have been prescribed to heart attack survivors as a standard treatment but the massive REBOOT trial has revealed they provide no benefit for patients with preserved heart function — and may actually increase risks for women.